Celldex Therapeutics, Inc (CLDX) Financials
Key financial figures for Celldex Therapeutics, Inc (Q1 2026).
- Revenue
- $15K
- Net Income
- -$79M
- EPS
- $-1.18
- Total Assets
- $511M
- Operating Cash Flow
- -$66M
Full income statement, balance sheet, and cash flow for Celldex Therapeutics, Inc on SentiSense.